Identification of BRAF as a New Interactor of PLC 1, the Protein Mutated in Nephrotic Syndrome Type 3

American Journal of Physiology - Renal Physiology - United States
doi 10.1152/ajprenal.00345.2007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

Identification of a Type-Specific Epitope in the ORF2 Protein of Duck Astrovirus Type 1

Animals
Animal ScienceZoologyVeterinary
2019English

Identification of a Novel Human Immunodeficiency Virus Type 1 Integrase Interactor, Gemin2, That Facilitates Efficient Viral cDNA Synthesis in Vivo

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

A New Type of Glycoconjugate Vaccine Containing Klebsiella Fimbriae Type 1 and 3 as Carrier Proteins

Critical Care
Critical CareIntensive Care Medicine
1997English

Development of Encorafenib for BRAF-mutated Advanced Melanoma

Current Opinion in Oncology
Cancer ResearchOncology
2018English

Pulmonary Embolism as First Sign of Nephrotic Syndrome

Srpski Arhiv Za Celokupno Lekarstvo
Medicine
2017English

Correction: PLC 1 as a Tumor Suppressor in ESCC

Cancer Research
Cancer ResearchOncology
2008English

New Abelson Interactor-1(Abi-1)-Driven Mechanism of Acquired Drug Resistance

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2014English

A Rare Case Report of Nephrotic Syndrome Minimal Type With Wilson Disease

Journal of Medical Science And clinical Research
2019English

Treatment of the Nephrotic Syndrome

The Lancet
Medicine
1951English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy